The efficacy of atezolizumab plus bevacizumab in the treatment of unresectable hepatocellular carcinoma in cirrhotic and non-cirrhotic patients

被引：0
|
作者：
Aranda-Gutierrez, Alejandro [1 ]
Conde-Flores, Emilio [1 ]
Meraz-Brenez, Andres [1 ]
Escorza, Salvador [1 ]
Meneses-Medina, Monica I. Isabel [1 ]
Huitzil-Melendez, Fidel David [1 ]
de la Mora-Molina, Hector [1 ]
Rosas Camargo, Vanessa [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16214
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Hepatocellular carcinoma in non-cirrhotic liver: A reappraisal
    Trevisani, Franco
    Frigerio, Marta
    Santi, Valentina
    Grignaschi, Alice
    Bernardi, Mauro
    DIGESTIVE AND LIVER DISEASE, 2010, 42 (05) : 341 - 347
  • [22] Hepatocellular Carcinoma in a Non-Cirrhotic with Hereditary Hemochromatosis
    Behazin, Nancy
    Jeffries, Mark
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 : S411 - S412
  • [23] HEPATOCELLULAR-CARCINOMA IN NON-CIRRHOTIC LIVERS
    SMALLEY, S
    MOERTEL, C
    FLEMING, T
    HILTON, J
    MELTON, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 156 - 156
  • [24] Dysregulated microRNAs in non-cirrhotic hepatocellular carcinoma
    Yang Seok Koh
    Jin Hee Kim
    Hua Cai
    Li-Hua Li
    Hyung-Seok Kim
    Kabsun Kim
    Nacksung Kim
    Boo Ahn Shin
    Taewon Lee
    Seok-Yong Choi
    Chol Kyoon Cho
    Genes & Genomics, 2013, 35 : 759 - 765
  • [25] Hepatocellular carcinoma in cirrhotic versus non-cirrhotic liver: Treatment and survival differences in a nationwide cohort
    Engstrand, Jennie
    Stal, Per
    Gilg, Stefan
    Jansson, Anders
    Stromberg, Cecilia
    SCANDINAVIAN JOURNAL OF SURGERY, 2024, 113 (02) : 120 - 130
  • [26] Liver resection for hepatocellular carcinoma in patients with normal, non-normal non-cirrhotic and cirrhotic liver
    Zanella, M. C.
    Toso, C.
    Rubbia-Brandt, L.
    Giostra, E.
    Terraz, S.
    Majno, P.
    Mentha, G.
    SWISS MEDICAL WEEKLY, 2010, 140 : 20S - 20S
  • [27] Outcomes and safety of DAA treatment in HCV cirrhotic patients treated with Atezolizumab- Bevacizumab for hepatocellular carcinoma
    Stella, L.
    Cabibbo, G.
    Iavarone, M.
    Piscaglia, F.
    Tovoli, F.
    Marra, F.
    Mazzarelli, C.
    Tortora, R.
    Aghemo, A.
    De Nicola, S.
    Bhoori, S.
    Pallozzi, M.
    Gasbarrini, A.
    Cerrito, L.
    Ponziani, F. R.
    DIGESTIVE AND LIVER DISEASE, 2025, 57
  • [28] Hepatocellular Carcinoma (HCC) in Patients with Non-Cirrhotic and Cirrhotic Nonalcoholic Fatty Liver Disease.
    Dakhoul, Lara
    Mcshane, Chelsey
    Jones, Keaton
    Ghabril, Marwan
    Vuppalanchi, Raj
    Samala, Niharika
    Vilar-Gomez, Eduardo
    Maluccio, Mary A.
    Chalasani, Naga P.
    Gawrieh, Samer
    HEPATOLOGY, 2017, 66 : 1118A - 1118A
  • [29] Variceal bleeding following treatment with atezolizumab plus bevacizumab in two patients with unresectable hepatocellular carcinoma
    Matsui, Teppei
    Nagai, Hidenari
    Mukozu, Takanori
    Wakui, Noritaka
    Matsuda, Takahisa
    Igarashi, Yoshinori
    CLINICAL JOURNAL OF GASTROENTEROLOGY, 2024, 17 (06) : 1058 - 1066
  • [30] Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients
    Van Roey, G
    Fevery, J
    Van Steenbergen, W
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2000, 12 (01) : 61 - 66
12345